Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.440
-0.040 (-2.70%)
At close: Apr 25, 2025, 4:00 PM
1.440
0.00 (0.00%)
Pre-market: Apr 28, 2025, 5:10 AM EDT
Humacyte Employees
As of December 31, 2024, Humacyte had 220 total employees, including 218 full-time and 2 part-time employees. The number of employees increased by 35 or 18.92% compared to the previous year.
Employees
220
Change (1Y)
35
Growth (1Y)
18.92%
Revenue / Employee
n/a
Profits / Employee
-$675,914
Market Cap
223.37M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 220 | 35 | 18.92% |
Dec 31, 2023 | 185 | 21 | 12.80% |
Dec 31, 2022 | 164 | 18 | 12.33% |
Dec 31, 2021 | 146 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
HUMA News
- 4 weeks ago - Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 4 weeks ago - Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025 - GlobeNewsWire
- 4 weeks ago - Humacyte, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 4 weeks ago - Humacyte, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 6 weeks ago - Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics - GlobeNewsWire
- 7 weeks ago - Trestle Bio Announces Research Collaboration with Humacyte - Business Wire
- 7 weeks ago - Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025 - GlobeNewsWire